Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IITerminatedFeb 20, 2019Prednisolone and Moxifloxacin Ophthalmic Solution 1%/0.5%Lack of sterility assurance.Promise Pharmacy, LLC · D-0432-2019Class IITerminatedFeb 20, 2019Acetylcysteine Ophthalmic SolutionLack of sterility assurance.Promise Pharmacy, LLC · D-0431-2019Class ITerminatedFeb 13, 2019the silver bullet 10x CapsulesMarketed without an Approved NDA/ANDA; FDA analysis found product to be tainted with undeclared sildenafil and tadalafilNatures Rx · D-0500-2019Class IIITerminatedFeb 13, 2019Bimatoprost Ophthalmic Solution 0.03%Failed Impurities/Degradation Specifications: OOS results observed in any other individual impurity and total impurities.Lupin Pharmaceuticals Inc. · D-0429-2019Class IITerminatedFeb 13, 2019Medline Remedy Essential Barrier Skin Protectant OintmentGMP Deviations: Out of specification results for Total Aerobic Microbial count in excipient purified water sampleUS Pharmaceuticals Inc. · D-0427-2019Class IITerminatedFeb 13, 2019Hydrocortisone Cream 1% MS Anti itch Cream with Intensive Healing 2 oz tubesGMP Deviations: Out of specification results for Total Aerobic Microbial count in excipient purified water sampleUS Pharmaceuticals Inc. · D-0426-2019Class IITerminatedFeb 13, 2019Soothe & Cool Protect Moisture Guard Skin ProtectantGMP Deviations: Out of specification results for Total Aerobic Microbial count in excipient purified water sampleUS Pharmaceuticals Inc. · D-0425-2019Class IITerminatedFeb 13, 2019DymistaDefective Container: Potential for broken glass in the neck area of the glass bottles.Mylan Pharmaceuticals Inc. · D-0424-2019Class IITerminatedFeb 6, 2019Fexofenadine HCl TabletsFailed Impurities/Degradation Specifications: Related compound results obtained during routine stability testing was slightly elevated above specification.Mylan Pharmaceuticals Inc. · D-0428-2019Class IITerminatedFeb 6, 2019Cephalexin for Oral Suspension USP 250mg/5 mLCGMP Deviations; presence of extraneous material in the was observed in area that is between the primary package that is heat sealed and secondary packaging (poly-woven...Lupin Pharmaceuticals Inc. · D-0423-2019Class IITerminatedFeb 6, 2019BromSiteBromfenac Ophthalmic Solution, 0.075% (Sterile 5 mL) may have a lack of sterility assurance.Sun Pharmaceutical Industries, Inc. · D-0422-2019Class IITerminatedFeb 6, 2019Domperidone 10 mg capsulesLack of Processing Controls.Duren Health Mart Pharmacy · D-0421-2019Class IITerminatedFeb 6, 2019Progesterone 100 mg SR capsulesLack of Processing Controls.Duren Health Mart Pharmacy · D-0420-2019Class IITerminatedFeb 6, 2019Promethazine Gel 50 mg/mLLack of Processing Controls.Duren Health Mart Pharmacy · D-0419-2019Class IITerminatedFeb 6, 2019Testosterone 0.1% creamLack of Processing Controls.Duren Health Mart Pharmacy · D-0418-2019Class IITerminatedFeb 6, 2019Progesterone 10% creamLack of Processing Controls.Duren Health Mart Pharmacy · D-0417-2019Class IITerminatedFeb 6, 2019Omeprazole 4 mg/mL SuspensionLack of Processing Controls.Duren Health Mart Pharmacy · D-0416-2019Class IITerminatedFeb 6, 2019GENTAMICIN OPTH-SOL 5ml Compare: Garamycin. 5-mL plastic dropper bottlePresence of Particulate Matter: Crystalline particles were noticed by manufacturer at the 24 month clarity testing.H J Harkins Company Inc dba Pharma Pac · D-0415-2019Class IITerminatedFeb 6, 2019Gentamicin Sulfate Ophthalmic SolutionPresence of Particulate Matter: Crystalline particles were noticed at the 24 month clarity testing.Akorn, Inc. · D-0414-2019Class IICompletedFeb 6, 2019Irbesartan and Hydrochlorothiazide TabletsCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Prinston Pharmaceutical Inc · D-0413-2019Class IICompletedFeb 6, 2019Irbesartan and Hydrochlorothiazide TabletsCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Prinston Pharmaceutical Inc · D-0412-2019Class IICompletedFeb 6, 2019Irbesartan and Hydrochlorothiazide TabletsCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Prinston Pharmaceutical Inc · D-0411-2019Class IICompletedFeb 6, 2019Irbesartan and HydrochlorothiazideTabletsCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Prinston Pharmaceutical Inc · D-0410-2019Class IICompletedFeb 6, 2019Irbesartan Tablets 300 mgCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Prinston Pharmaceutical Inc · D-0409-2019Class IITerminatedJan 30, 2019HEPERAIN 50 mg/50 mLLabeling; Label Error on Declared Strength; label incorrectly states the concentration as 50 mg/50 mL (1 mg/mL) rather than the fully accurate concentration as 50...Advanced Pharma Inc. · D-0430-2019Class IIITerminatedJan 30, 2019LOPERAMIDE HCL TABLETS USPLabeling Not Elsewhere Classified: The front panel indicates 24 caplets whereas the side panel indicates 12 caplets. The drug product carton contains 24 caplets.Sun Pharmaceutical Industries, Inc. · D-0391-2019Class IITerminatedJan 30, 2019Fluocinolone Acetonide Topical SolutionFailed Impurities/Degradation Specifications: Expansion of October 2018 recall due to elevated out of specification results for total impurities that have been...Lupin Somerset · D-0390-2019Class IITerminatedJan 30, 2019Ezetimibe and Simvastatin Tablets 10mg/80 mgPresence of Foreign Substance: Product complaint of black speckles observed on tablets.Dr. Reddy's Laboratories, Inc. · D-0389-2019Class ITerminatedJan 30, 20195K Premium Enhancement capsuleMarketed without an Approved NDA/ANDA; FDA analysis found product to be tainted with undeclared sildenafil and tadalafilHappy Together, Inc. · D-0388-2019Class IITerminatedJan 30, 2019Curaplex Epi Kit NOT FOR IV USELabeling Incorrect Instructions: This recall has been initiated because the Instructions for Use included in the Epi-Safe Kits for the Epi-Safe Syringe (and/or the...Bound Tree Medical, LLC · D-0386-2019Class IITerminatedJan 30, 2019Curaplex Epi Safe KitLabeling Incorrect Instructions: This recall has been initiated because the Instructions for Use included in the Epi-Safe Kits for the Epi-Safe Syringe (and/or the...Bound Tree Medical, LLC · D-0385-2019Class IITerminatedJan 30, 2019curaplex Epi Safe KitLabeling Incorrect Instructions: This recall has been initiated because the Instructions for Use included in the Epi-Safe Kits for the Epi-Safe Syringe (and/or the...Bound Tree Medical, LLC · D-0384-2019Class IITerminatedJan 30, 2019curaplex Epi Safe Administration and Training KitsLabeling Incorrect Instructions: This recall has been initiated because the Instructions for Use included in the Epi-Safe Kits for the Epi-Safe Syringe (and/or the...Bound Tree Medical, LLC · D-0383-2019Class IITerminatedJan 23, 2019Olmesartan Medoxomil and Hydrochlorothiazide TabletsFailed dissolution specificationsTeva Pharmaceuticals USA · D-0381-2019Class IITerminatedJan 23, 2019Cephalexin for Oral Suspension USPCGMP Deviation; manufacturing batch record could not be locatedLupin Pharmaceuticals Inc. · D-0380-2019Class IIITerminatedJan 23, 2019Curaplex Epi Safe KitLabeling: Incorrect or missing Lot and/or Exp Date:The Kit is incorrectly labeled as expiring May 2018 however the correct expiration date is May 2019. In addition...Bound Tree Medical, LLC · D-0379-2019Class IITerminatedJan 23, 2019EEMT (esterified estrogens and methyltestosterone) 1.25 mg/2.5 mgCGMP deviations: Lots were recalled due to sub-potency and cGMP violations.Syntho Pharmaceuticals, Inc. · D-0378-2019Class IITerminatedJan 23, 2019EEMT HSCGMP deviations: Lots were recalled due to sub-potency and cGMP violations.Syntho Pharmaceuticals, Inc. · D-0377-2019Class IITerminatedJan 23, 2019curaplex Epi Safe Administration and Training Kits # 8600-01100. Kit contains 2 Epi Safe Administration KitLabeling: Incorrect or Missing Lot and/or Exp date: vials of epinephrine within kit 8600-01100 expired on December 2018, but the outer kit label has an expiration date...Bound Tree Medical, LLC · D-0371-2019Class IIOngoingJan 23, 2019Valsartan tablets USP 320 mgCGMP Deviations: FDA lab confirmed presence an impurity, N-nitrosodimethylamine (NDEA) contained in the API used to manufacture the product above the interim acceptable...Aurobindo Pharma USA Inc. · D-0370-2019

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.